Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
14
Number of overlapping holdings
63.6%
% of PJP's 22 holdings also in XPH
34.1%
% of XPH's 41 holdings also in PJP
Overlap by Weight
Sector Drift (PJP minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PJP |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
PFIZER INC | 5.9% | 4.1% | 4.1% |
|
JOHNSON & JOHNSON | 6.0% | 4.0% | 4.0% |
|
ELI LILLY & CO | 6.0% | 3.7% | 3.7% |
|
MERCK & CO. INC. | 5.6% | 3.6% | 3.6% |
 |
JAZZ PHARMACEUTICALS PLC | 3.6% | 3.6% | 3.6% |
Position Highlights (Non-Overlapping Exposures)
PJP Overweight Relative to XPH
|
ABBVIE INC | 6.2% |
|
AMGEN INC | 6.2% |
|
REGENERON PHARMACEUTICALS | 6.1% |
|
ABBOTT LABORATORIES | 5.6% |
|
GERON CORP | 4.8% |
|
UNITED THERAPEUTICS CORP | 4.3% |
|
GILEAD SCIENCES INC | 4.0% |
|
BIOGEN IDEC INC | 3.6% |
|
INNOVIVA, INC. | 2.6% |
|
ELI LILLY & CO | 2.3% |
PJP Underweight Relative to XPH
|
VIATRIS, INC. | -4.4% |
|
AXSOME THERAPEUTICS, INC. | -4.3% |
|
INTRA-CELLULAR THERAPIES INC | -4.1% |
|
ZOETIS INC | -3.9% |
|
ROYALTY PHARMA PLC CLASS A | -3.9% |
|
CATALENT INC | -3.9% |
|
BRISTOL-MYERS SQUIBB CO | -3.9% |
|
ORGANON & CO. | -3.8% |
|
ARVINAS, INC. | -3.5% |
|
ELANCO ANIMAL HEALTH, INC. | -2.6% |